Can I Take Stendra (Avanafil) While Breastfeeding?

Published on September 3rd, 2026. Updated on September 3rd, 2026.

Key takeaways

  • No human breast milk data exists for avanafil, making its safety genuinely unknown right now.

  • Avanafil's short half-life matters but cannot make timing-based workarounds reliably safe alone.

  • PDE5 inhibitors have weak evidence for female sexual dysfunction, making the risk-benefit calculation critical.

  • Sildenafil has more published lactation data than avanafil and may be a more informed choice.

  • A breastfeeding medicine specialist is the right expert to consult before taking any PDE5 inhibitor.

Is Avanafil Safe to Take While Breastfeeding?

If you were prescribed Stendra (avanafil) and you are nursing, the straightforward answer is that nobody knows for certain whether it is safe. No published human studies have measured avanafil in breast milk, so the risk is unknown rather than confirmed harmful. Most clinicians advise against it while nursing precisely because the safety gap has not been filled, not because harm has been proven.

Avanafil is FDA-approved only for men with erectile dysfunction. Any use in postpartum women is entirely off-label, meaning your doctor is applying the drug outside its studied and approved population. That does not make the prescription wrong, but it does mean the evidence base is thinner than you might expect.

What Do We Actually Know About How Avanafil Works in the Body?

Understanding a drug's pharmacology (how the body processes it) can offer clues about breast milk transfer, even when direct data is missing.

Here is what the science does tell us about avanafil:

  • Half-life of 3 to 5 hours. This means the drug clears your system relatively quickly compared to tadalafil, which can linger for up to 17 hours.
  • High protein binding at 99%. Drugs tightly bound to proteins in the bloodstream tend to pass into breast milk in smaller amounts. This is theoretically reassuring, but it has not been tested in nursing humans.
  • Animal reproductive studies show no clear signs of causing birth defects, but animal data do not reliably predict what happens during human lactation.

The short half-life is relevant to any conversation about timing doses around feeding sessions. However, without actual pharmacokinetic data in breast milk, a firm safe-waiting window cannot be established. Treating the half-life as a workaround is not clinically supported right now.

How Does Avanafil Compare to Other PDE5 Inhibitors for Nursing Mothers?

PDE5 inhibitors (drugs that relax smooth muscle by blocking a specific enzyme) are poorly studied as a class in breastfeeding women. The comparison below reflects the best available evidence, and the judgment column matters here.

Drug

Half-Life

Human Lactation Data Available

Relative Caution Level for Nursing Mothers

Avanafil (Stendra)

3 to 5 hours

None published

Highest caution: no data at all

Sildenafil (Viagra)

3 to 5 hours

Limited, mainly pulmonary hypertension use

Moderate caution: some data, still off-label

Tadalafil (Cialis)

Up to 17 hours

None robust

High caution: long half-life adds concern

Vardenafil (Levitra)

4 to 5 hours

None published

High caution: no data, rarely discussed

Sildenafil stands out slightly because it is sometimes prescribed off-label to postpartum women for pulmonary hypertension (high blood pressure in the lung's arteries), which has produced at least some lactation observations. That gives it a marginally better-characterized safety profile, though it is still far from fully studied.

Why Would a Breastfeeding Woman Be Prescribed Avanafil?

Postpartum sexual dysfunction, including reduced libido and difficulty with arousal, is common and genuinely underaddressed in clinical care. Some clinicians explore PDE5 inhibitors off-label for female sexual arousal disorder, which is why a nursing mother might receive this prescription.

It is worth being direct about the evidence here: studies on PDE5 inhibitors for female sexual dysfunction have produced mostly weak or mixed results. The FDA has not approved any PDE5 inhibitor for sexual dysfunction in women. That does not mean every prescription is inappropriate, but it does mean the expected benefit should be weighed carefully against an unknown breastfeeding risk.

If you were prescribed avanafil for postpartum sexual concerns, these questions are worth asking your provider:

  • Why avanafil specifically? Sildenafil has more lactation observations and the same general mechanism.
  • What non-medication options were considered? Pelvic floor physical therapy, lubricants, and counseling carry no milk-transfer risk.
  • What is the plan if symptoms do not improve? Off-label prescribing should come with a clear reassessment point.

What Should You Do If Your Doctor Recommends Avanafil While Nursing?

The right response is not to panic and not to simply fill the prescription without a follow-up conversation. Here is a practical path forward.

First, ask your prescriber directly why avanafil was selected over alternatives with more lactation safety data. A good prescriber will welcome that question.

Second, request a consultation with a breastfeeding medicine specialist or clinical pharmacologist. These specialists can weigh your infant's age, how frequently you nurse, your overall health, and your personal risk tolerance in a way that a general prescription cannot.

Third, do not rely on a timing strategy alone. While spacing a dose away from a feeding session is intuitive given the short half-life, no pharmacokinetic data in breast milk exists to back up a specific window. The strategy may offer some margin, but it cannot be called reliably safe.

Red Flags That Require Immediate Attention

If you took avanafil while breastfeeding and notice any of the following in your infant, contact a provider promptly:

  • Unusual drowsiness or difficulty waking
  • Trouble latching or feeding
  • Unexplained irritability

For the mother, avanafil carries known cardiovascular risks. Seek emergency care immediately for sudden low blood pressure (feeling faint or dizzy when you stand), chest pain, or a prolonged or painful erection if the drug was mistakenly taken by a partner. These are not theoretical risks and should not be waited out.

Doctronic offers 24/7 HIPAA-compliant consultations and has supported more than 22 million AI consultations with a 99.2% treatment plan alignment with board-certified physicians. It can be a fast, structured starting point for organizing your medication safety questions before you meet with a specialist in person.

Frequently Asked Questions

No human studies have measured avanafil in breast milk. Its high protein binding may limit transfer in theory, but without actual data, no one can say how much, if any, reaches a nursing infant.

Avanafil's half-life is roughly 3 to 5 hours, but without pharmacokinetic data in breast milk, a firm waiting window cannot be recommended. Talk to a breastfeeding medicine specialist before relying on timing alone.

None is approved or clearly established as safe for nursing mothers. Sildenafil has the most published lactation data of the class, but robust safety evidence is still lacking for all PDE5 inhibitors in this population.

Yes. Pelvic floor physical therapy, lubricants, hormonal options evaluated with your provider, and couples counseling are non-systemic approaches with better-characterized safety profiles for breastfeeding mothers.

Tell your provider you are nursing and ask why avanafil was chosen over alternatives with more lactation data. Request a review with a breastfeeding medicine specialist or clinical pharmacologist before filling the prescription.

The Bottom Line

The honest answer about avanafil and breastfeeding is not 'it is dangerous' but 'we simply do not know.' No human studies have examined how much of this drug enters breast milk, and no regulatory body has cleared it for nursing mothers. Postpartum sexual health is real and worth addressing, and that is exactly why a blanket yes or no does not serve you well here. The risk-benefit calculation depends on your infant's age, feeding frequency, and whether safer alternatives were considered. Doctronic, the first AI legally authorized to practice medicine, has handled over 22 million AI consultations and can help you organize your questions before you speak with a specialist. Start there, then confirm any plan with a licensed clinician, especially for new, worsening, or high-risk symptoms.

Get women's health advice

Chat Now